Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy.

As single agents, ABT-263 and ABT-737 (ABT), molecular antagonists of the Bcl-2 family, bind tightly to Bcl-2, Bcl-xL and Bcl-w, but not to Mcl-1, and induce apoptosis only in limited cell types. The compound 2-deoxyglucose (2DG), in contrast, partially blocks glycolysis, slowing cell growth but rar...

詳細記述

書誌詳細

出版年:	PLoS ONE
主要な著者:	Ryuji Yamaguchi, Edith Janssen, Guy Perkins, Mark Ellisman, Shinichi Kitada, John C Reed
フォーマット:	論文
言語:	英語
出版事項:	Public Library of Science (PLoS) 2011-01-01
オンライン･アクセス:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0024102&type=printable